Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Marsden

Showing results (251-260 of 1,050) with videos related to

Pageof 105
Sort By:
Advances in Neurology|January 1, 1976
Paternal age effect in isolated juvenile torison dystoniaS Bundey, M J Harrison, C D Marsden
Biochemical Pharmacology|October 15, 1986
Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the ratM D Simpson, P Jenner, C D Marsden
Neurology|October 1, 1989
Botulinum toxin in torticollisR Stell, P D Thompson, C D Marsden
British Journal of Clinical Pharmacology|January 1, 1977
Nomifensine in Parkinson's diseaseP Bedard, J D Parkes, C D Marsden
The Journal of Pharmacy and Pharmacology|May 1, 1985
Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPSG J Kilpatrick, P Jenner, C D Marsden
Brain : a Journal of Neurology|April 1, 1992
Simple and choice reaction time and the use of advance information for motor preparation in Parkinson's diseaseM Jahanshahi, R G Brown, C D Marsden
Advances in Neurology|January 1, 1997
An introduction to the new surgery for Parkinson's disease. Past and present problemsC D Marsden, G Linazasoro, J A Obeso
Neurology|December 1, 1992
New insights into the cause of Parkinson's diseaseP Jenner, A H Schapira, C D Marsden
Journal of Neurology, Neurosurgery, and Psychiatry|August 17, 1999
Sleep benefit in Parkinson's diseaseD E Bateman, K Levett, C D Marsden
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1975
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesiasD Tarsy, J D Parkes, C D Marsden
Pageof 105

Showing results (251-260 of 1,050) with videos related to

Sort By:
Pageof 105
Advances in Neurology|January 1, 1976
Paternal age effect in isolated juvenile torison dystoniaS Bundey, M J Harrison, C D Marsden
Biochemical Pharmacology|October 15, 1986
Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the ratM D Simpson, P Jenner, C D Marsden
Neurology|October 1, 1989
Botulinum toxin in torticollisR Stell, P D Thompson, C D Marsden
British Journal of Clinical Pharmacology|January 1, 1977
Nomifensine in Parkinson's diseaseP Bedard, J D Parkes, C D Marsden
The Journal of Pharmacy and Pharmacology|May 1, 1985
Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPSG J Kilpatrick, P Jenner, C D Marsden
Brain : a Journal of Neurology|April 1, 1992
Simple and choice reaction time and the use of advance information for motor preparation in Parkinson's diseaseM Jahanshahi, R G Brown, C D Marsden
Advances in Neurology|January 1, 1997
An introduction to the new surgery for Parkinson's disease. Past and present problemsC D Marsden, G Linazasoro, J A Obeso
Neurology|December 1, 1992
New insights into the cause of Parkinson's diseaseP Jenner, A H Schapira, C D Marsden
Journal of Neurology, Neurosurgery, and Psychiatry|August 17, 1999
Sleep benefit in Parkinson's diseaseD E Bateman, K Levett, C D Marsden
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1975
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesiasD Tarsy, J D Parkes, C D Marsden
Pageof 105